Repros jumps on FDA go-ahead for testosterone drug study

[riky]

Repros jumps on FDA go-ahead for testosterone drug study

(Reuters) - Repros Therapeutics Inc said U.S. health regulators agreed with its plan to continue analyzing data from a late-stage study of its experimental testosterone drug, putting the company on track to report trial data in the third quarter and sending its shares up 45 percent. The company last month pushed back the expected date to report data from the first of two late-stage studies on its drug Androxal after it found that the patient population at a site where the drug was being tested was markedly different from 16 other sites. ...

Source: You are not allowed to view links. Register or Login